Media OutReach
Immuno Cure Kicks off Phase I Clinical Study of Therapeutic DNA Vaccine for HIV in Hong Kong
As a lead candidate under Immuno Cure’s patented “PD-1-Enhanced DNA Vaccine Technology Platform”, ICVAX aims to achieve sustained, immune-mediated HIV-1 virological control without the need of antiretroviral therapy. Following the successful first-in-human ICVAX Phase I clinical trial in Shenzhen that showed exceptional safety and immunogenicity profiles, this clinical study will explore the safety and immunogenicity of ICVAX in HIV-infected volunteers in Hong Kong, to be administered by three distinct delivery systems. This comparative approach will provide essential data on the optimal delivery method for ICVAX, and hence potentially identifying the most effective, patient-friendly and scalable option for enhancing immunotherapeutic responses in people living with HIV.
The clinical study will be conducted at Prince of Wales Hospital and will be led by Dr Grace LUI, Head of the Division of Infectious Diseases at CUHK Medicine’s Department of Medicine and Therapeutics, as the Principal Investigator. This is a randomized clinical study to evaluate the immunogenicity and safety of ICVAX in a total of 22 HIV-infected volunteers using three delivery systems: Teresa-EPT-1 electroporation device, PharmaJet’s Tropis, a WHO pre-qualified needle-free injection system, and PapiVax’s TriGrid EP device.
This study has been granted ΗΚ$4.2 million funding under the Public Sector Trial Scheme of the Innovation and Technology Fund of the HKSAR Government (project reference number: UTT/002/23GM). Professor Zhiwei CHEN, Director of the HKU AIDS Institute and Principal Scientific Advisor of Immuno Cure, serves as the Project Coordinator for this funding. This study is also partially supported by Theme-based Research Scheme (TRS) of the Research Grants Council under the University Grants Committee of the Education Bureau (project reference number: T11-702/24-N).
“This Phase I clinical study is an important landmark, being the first evaluation of ICVAX in Hong Kong volunteers and incorporating multiple innovative delivery technologies,” said Dr Grace LUI. “By testing these devices, we aim to optimize safety, immunogenicity, and patient experience for this promising HIV therapeutic DNA vaccine candidate.”
“ICVAX is built on the innovative PD-1-Enhanced DNA vaccine technology invented and developed locally at the HKU,” said Professor Zhiwei CHEN. “This study will help optimize delivery of ICVAX, paving the way for broader international deployment.”
“The launch of this clinical study is a major milestone of vaccine development for Immuno Cure,” said Dr Xia JIN, CEO of Immuno Cure. “By testing ICVAX for the first time in Hong Kong and comparing three innovative delivery devices this study not only advances our understanding of the performance of our DNA medicines, but also significantly supports the global commercialization of ICVAX and our other DNA medicines. Immuno Cure is committed to leading innovation in immunotherapy to combat infectious diseases and cancers.”
Hashtag: #ImmunoCure
The issuer is solely responsible for the content of this announcement.
About Immuno Cure
Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine Platform and Anti-Δ42PD1 Antibody Platform
To learn more about Immuno Cure, please visit http://www.immunocure.hk.
About CUHK Medicine
Established in 1981, CU Medicine has achieved international recognition in teaching, research, and clinical practice and is the youngest medical school ranked among the world’s top 25 in many global rankings. In the “Best Global Universities Subject Rankings 2025-26” by U.S. News and World Report, its “Gastroenterology and Hepatology”, “Endocrinology and Metabolism” and “Clinical Medicine” programmes rank 1st in Asia, while Gastroenterology and Hepatology claims 2nd globally.
The Faculty comprises 14 clinical departments and five schools, delivering a world-class environment for teaching and research with a strong emphasis on interdisciplinary, interprofessional, and international collaboration. To date, it has cultivated over 6,000 medical graduates who are making an impact across local and global healthcare systems. The Faculty is dedicated to driving innovation by translating groundbreaking research into real-world clinical applications. Its contributions have reshaped medicine — evidenced by the filing of 3,000 patents, strategic patent acquisitions, and the establishment of more than 20 start-ups. Its pioneering research has not only rewritten international clinical guidelines but also revolutionised the prevention, diagnosis, and treatment of numerous diseases.
To learn more about CU Medicine, please visit http://www.med.cuhk.edu.hk.
About HKU AIDS Institute
HKU AIDS Institute was established in November 2007 to take HKU in a new strategic direction in fighting this global epidemic and help to make it a leader in the region in AIDS research, education and prevention. Scientists at the AIDS Institute are fully committed to conducting basic and applied research that facilitates the understanding of AIDS pathogenesis and the development of effective AIDS vaccines. Currently, the Institute is leading the Hong Kong Theme-based Research Scheme entitled “Potentiating Host Immunity for HIV-1 Functional Cure”.
To learn more about HKU and AIDS Institute of HKU, please visit https://www.hku.hk/ and https://www.med.hku.hk/aidsinst/.
About BAY TRIAL
BAY TRIAL is a key initiative in implementing the “Notice of the State Council on Issuing the Development Plan for the Shenzhen Park of the Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone” (State Council [2023] No. 12). It serves as strong support for Shenzhen’s development as an international science and technology innovation centre and for promoting the high-quality development of the biopharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). Located in the Hetao Shenzhen-Hong Kong Cooperation Zone, BAY TRIAL leverages the zone’s unique geographical and policy advantages to integrate clinical trial innovation resources across the GBA, deepen Shenzhen-Hong Kong science and technology collaboration, and establish a one-stop clinical trial platform.
To learn more about BAY TRIAL, please visit: https://baytrial.smart.org.cn/about/index.html
Recruited from 12 universities, including Hainan University and Hainan Normal University, as well as other local organizations, the volunteers share the common nickname “Little Deer.” The name is derived from Sanya’s nickname, “Deer City,” and is meant to reflect the volunteers’ lively, warm, and friendly spirit.
“See ya in Sanya” is both the slogan of the Asian Beach Games and the guiding principle for its volunteers. Liang Zihan, a student from Hainan Tropical Ocean University, said: “Since the launch of the volunteer recruitment drive, whether it is learning about the Games, mastering multilingual communication, or taking part in scenario-based drills and emergency exercises, I have given it my all. I hope to convey Sanya’s warmth, openness, and inclusiveness to every friend who comes from afar.”
Alongside local students, the volunteer team also includes many young people from across China brought together by the Games. Wu Yujia, a sophomore at the Hospitality Institute of Sanya, is one of them. “I want to show a warm, caring, and energetic Sanya,” she said. When asked about her future plans, she did not hesitate: “I want to stay in Sanya.” In her eyes, the city’s pleasant climate and beautiful scenery have deepened her affection for it and strengthened her commitment to volunteering.
The 6th Asian Beach Games will be held in Sanya, Hainan, from April 22 to 30, 2026. Delegations from all 45 member countries and regions of the Olympic Council of Asia (OCA) will take part in what is the largest and most influential beach sports event in Asia. As the first major international sporting event to be held in Hainan after the independent customs operations of the Hainan Free Trade Port, the Games are not only a celebration of Asian sport but also an important opportunity for Hainan to present an open and welcoming face to the world.
The issuer is solely responsible for the content of this announcement.
Media OutReach
SERES’ Clifford Kang Highlights AI-Enabled Smart Mobility at the 2026 World Internet Conference Asia-Pacific Summit
The summit, hosted by the World Internet Conference and organised by the Government of the Hong Kong Special Administrative Region, brought together global industry leaders to explore developments in digital and intelligent transformation.
Against this backdrop, Kang noted that artificial intelligence is accelerating a fundamental shift across industries, with mobility among the most significantly transformed sectors. AI is moving from merely functional to truly frictionless, becoming deeply embedded in every part of our lives and emerging as an inclusive force that enhances mobility, living and consumption experiences.
As this transformation accelerates, SERES continues to embed intelligence across its full value chain, from product development to manufacturing and user services, using continuous innovation to enhance user experience and strengthen its long-term competitiveness as a technology-driven new energy vehicle company.
A key milestone of SERES came in 2021, when SERES entered a cross-industry partnership with Huawei to launch the AITO brand, its premium new energy vehicle brand. At the time, the industry was facing a clear disconnect, where intelligent cars were not luxurious, while luxury cars were not intelligent. In response, AITO introduced the brand philosophy of “Intelligence Redefining Luxury”, positioning intelligence as the foundation of its premium mobility experience. The brand name itself, derived from “adding intelligence to auto”, reflects this core DNA.
Today, that strategy has translated into scale and adoption. AITO has built a user base of more than 880,000 active users of its smart driving assistance system, with total journeys surpassing 6.6 billion kilometres.
Clifford Kang further emphasised that a great product alone is not enough, and that company need to focus on the entire lifecycle user experience. Guided by this principle, SERES has extended intelligent technologies at scale across both manufacturing and customer service to improve every touchpoint.
In manufacturing, the SERES Super Factory, operates with more than 5,000 robots, enabling 100% automation of critical processes. AI vision inspection technology ensures strict quality control of key components, ensuring high quality standards across production.
On the customer service end, SERES has built a 24/7 cloud-based safety service system powered by AI and big data, enabling a shift from reactive support to intelligent predictive service. In 2025 alone, the system delivered approximately 250,000 proactive alerts to customers. One notable example came in July last year, when AITO M9 completed the industry’s first satellite-enabled rescue operation in a remote region of China, highlighting both the practical value and human warmth of intelligent connected technologies in real-world scenarios.
Looking ahead, Clifford Kang stated that new energy vehicles are evolving into the mobile intelligent space, requiring further robust investment in research and development. In 2025 alone, SERES invested RMB 12.5 billion in R&D, representing a 77% year-on-year increase. This investment has enabled the company to develop a suite of core technologies, including the SERES MF Platform, Super Range Extender and Intelligent Safety systems. These innovations are continuously applied across SERES’ products to enhance performance and deliver better mobility experiences for users.
“Bringing eruptive technology from the laboratory to the road requires more than one company’s efforts”, Kang said. “Open collaboration is the most efficient path forward. SERES has always embraced openness and partnership. We want to work with industry partners around the world to advance the mobility sector together. Let’s build up the future where technology has the vision to lead, the precision to excel, and the warmth to care.”
Hashtag: #SERESGroup
The issuer is solely responsible for the content of this announcement.
About Seres Group
Seres Group is one of China’s leading luxury new energy vehicle companies. Its premium brand AITO has surpassed one million cumulative users. In 2025 AITO became the best-selling Chinese luxury car brand in the domestic market. With strong capabilities in areas such as intelligent driving, SERES is bringing its vision of “Intelligence Redefining Luxury” to global markets and delivering a smarter mobility experience to more users around the world.
The event featured a distinguished lineup of speakers who shared their insights on deepening cooperation. Gudrun Weidmann, Director for Internationalization at the Bavarian Ministry of Economic Affairs; Zhai Qian, Minister Counselor of the Chinese Embassy in Germany; Chen Xiaodong, Deputy Director of the Jiangsu Provincial Department of Commerce; Dr. Christian Scharpf, Deputy Mayor of Munich and Head of the Department of Labor and Economic Affairs, and Michaela Schenk, Chair of the Foreign Trade Committee of the Chamber of Commerce and Industry for Munich and Upper Bavaria, delivered opening remarks. The proceedings were moderated by Stefan Geiger, Chairman of the China-Western Bavaria Business and Cultural Association.
Chen Gao, Secretary of the CPC Taicang Municipal Committee, delivered a keynote address titled “Green, Innovation, and Integration: Establishing a Model for Sino-German Cooperation.” In his speech, Chen drew a poetic parallel between Munich and Taicang’s home region of Suzhou, describing both as paragons of the perfect fusion between tradition and modernity where cutting-edge technology and modern industry coexist harmoniously with rich cultural heritage.
Reflecting on 33 years of deep engagement with Germany, Chen emphasized that Taicang’s bilateral cooperation has reached a historic turning point, transitioning from merely attracting foreign capital to fostering two-way investment, and from industrial supply-chain support to the co-creation of a complete industrial ecosystem. The Secretary highlighted three flagship Taicang projects recently included in the official achievement list of the high-level Sino-German summit—the Schaeffler Humanoid Robot Digital Factory, the Sino-German Taicang Zero-Carbon Park, and the Taicang Rhine-Neckar Innovation Center. These milestones vividly demonstrate Taicang’s momentum in pivoting toward green transformation, collaborative innovation, and deep bilateral integration. Taicang’s strategy remains built on the philosophy of long-termism, with Chen reaffirming the city’s dedication to optimizing a market-oriented, law-based, and internationalized business environment while reinforcing its brand identity as a “home away from home” for German community.
Following these addresses, the event yielded several milestone agreements aimed at facilitating practical cooperation, including the official inauguration of the VDE China representative office in Taicang and the signing of a new batch of German scientific innovation projects. To further support the internationalization of local firms, the Taicang Enterprise Overseas Service Center was officially unveiled, alongside a dedicated matchmaking session for Chinese companies expanding into global markets. Furthermore, State Grid Taicang Power Supply Company presented its latest initiatives in Green Compliance and Environmental Sustainability, a presentation that received widespread acclaim for aligning industrial power solutions with international ESG standards.
Taicang’s strategic appeal is rooted in its premier location adjacent to Shanghai and its world-class infrastructure. Situated within a 30-minute commuting radius of central Shanghai, the city offers rapid access to Hongqiao Airport in 20 minutes and Pudong International Airport in just over an hour. Its maritime gateway, the Port of Taicang, features a 12.5-meter deep-water channel and ranks 8th in China and 20th globally, with an annual throughput exceeding 10 million TEUs. This logistics network supports a robust industrial ecosystem of over 5,000 enterprises, where 70% of vehicle components can be sourced locally.
Widely recognized as the “Home of German Enterprises” in China, Taicang now hosts over 560 German firms, including 60 “hidden champion” companies. This specialized cluster represents more than 10% of all German manufacturing enterprises in China. The city’s collaborative success is further evidenced by projects mentioned above in Chen Gao’s speech such as the Schaeffler Humanoid Robot Digital Factory and the Sino-German Taicang Zero-Carbon Park, and the Taicang Rhine-Neckar Innovation Center, all of which were included in the official achievement list of the German Chancellor’s visit to China.
To support its growing international community, Taicang has developed a sophisticated service ecosystem. The city’s Foreigner Service Center integrates 73 specialized services, supported by the “Hi Taicang” card which provides foreign residents with enhanced convenience in healthcare, education, and transportation. Complemented by cultural landmarks like the Rothenburg-themed street and authentic German bakeries, Taicang has created an environment where international partners can truly root themselves for long-term success.
Hashtag: #TIZ
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn